KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Net Cash Flow (2017 - 2025)

Guardant Health (GH) has disclosed Net Cash Flow for 9 consecutive years, with -$199.4 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 250.35% to -$199.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$140.8 million through Dec 2025, up 71.96% year-over-year, with the annual reading at -$140.8 million for FY2025, 71.96% up from the prior year.
  • Net Cash Flow hit -$199.4 million in Q4 2025 for Guardant Health, down from -$45.4 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $675.3 million in Q4 2023 to a low of -$356.9 million in Q2 2022.
  • Historically, Net Cash Flow has averaged -$16.9 million across 5 years, with a median of -$31.6 million in 2022.
  • Biggest five-year swings in Net Cash Flow: crashed 614.42% in 2022 and later surged 5365.04% in 2025.
  • Year by year, Net Cash Flow stood at -$339.9 million in 2021, then skyrocketed by 94.76% to -$17.8 million in 2022, then skyrocketed by 3892.93% to $675.3 million in 2023, then tumbled by 108.43% to -$56.9 million in 2024, then plummeted by 250.35% to -$199.4 million in 2025.
  • Business Quant data shows Net Cash Flow for GH at -$199.4 million in Q4 2025, -$45.4 million in Q3 2025, and -$69.3 million in Q2 2025.